Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients

Fanconi anemia (FA) is a rare hereditary disease resulting from an inactivating mutation in the FA/BRCA pathway, critical for the effective repair of DNA interstrand crosslinks (ICLs). The disease is characterized by congenital abnormalities, progressing bone marrow failure, and an increased risk of...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Oncogenesis (New York, NY) Ročník 13; číslo 1; s. 26 - 10
Hlavní autoři:	van Harten, Anne M., Shah, Ronak, de Boer, D. Vicky, Buijze, Marijke, Kreft, Maaike, Song, Ji-Ying, Zürcher, Lisa M., Jacobs, Heinz, Brakenhoff, Ruud H.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London Nature Publishing Group UK 11.07.2024 Nature Publishing Group
Témata:	13 13/100 13/106 13/109 13/31 13/51 13/89 14 14/1 14/34 14/56 38 42 45 631/154/1438 631/154/555 631/154/556 631/208/68 631/67/1536 82 82/80 Anemia Apoptosis Breast cancer Cell Biology Chemoradiotherapy Chemotherapy Cisplatin DNA repair Fanconi syndrome Gemcitabine Genetic screening Head & neck cancer Head and neck carcinoma Hemopoiesis Hereditary diseases Human Genetics Internal Medicine Malignancy Medicine Medicine & Public Health Nucleotide analogs Oncology Patients Radiation therapy Ribonucleotide reductase siRNA Squamous cell carcinoma Therapeutic targets Toxicity Tumor cell lines
ISSN:	2157-9024, 2157-9024
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!